Entity Details

Primary name MFN2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionO95140
EntryNameMFN2_HUMAN
FullNameMitofusin-2
TaxID9606
Evidenceevidence at protein level
Length757
SequenceStatuscomplete
DateCreated2004-05-24
DateModified2021-06-02

Ontological Relatives

GenesMFN2

GO terms

Show/Hide Table
GOName
GO:0003924 GTPase activity
GO:0005525 GTP binding
GO:0005739 mitochondrion
GO:0005741 mitochondrial outer membrane
GO:0005829 cytosol
GO:0006626 protein targeting to mitochondrion
GO:0006915 apoptotic process
GO:0006986 response to unfolded protein
GO:0007006 mitochondrial membrane organization
GO:0007596 blood coagulation
GO:0008053 mitochondrial fusion
GO:0016021 integral component of membrane
GO:0016236 macroautophagy
GO:0031306 intrinsic component of mitochondrial outer membrane
GO:0031625 ubiquitin protein ligase binding
GO:0034497 protein localization to phagophore assembly site
GO:0046580 negative regulation of Ras protein signal transduction
GO:0048662 negative regulation of smooth muscle cell proliferation
GO:0051646 mitochondrion localization
GO:0061734 parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization
GO:0120162 positive regulation of cold-induced thermogenesis
GO:1904707 positive regulation of vascular associated smooth muscle cell proliferation
GO:1905461 positive regulation of vascular associated smooth muscle cell apoptotic process

Subcellular Location

Show/Hide Table
Subcellular Location
Mitochondrion outer membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR006884 Fzo/mitofusin HR2 domainDomainDomain
IPR022812 DynaminFamilyFamily
IPR027089 Mitofusin-2FamilyFamily
IPR027094 Mitofusin familyFamilyFamily
IPR027417 P-loop containing nucleoside triphosphate hydrolaseFamilyHomologous superfamily
IPR030381 Dynamin-type guanine nucleotide-binding (G) domainDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
617087 OMIMCharcot-Marie-Tooth disease 2A2B (CMT2A2B)An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. CMT2A2B is a severe form with autosomal recessive inheritance. The disease is caused by variants affecting the gene represented in this entry.
601152 OMIMNeuropathy, hereditary motor and sensory, 6A, with optic atrophy (HMSN6A)An autosomal dominant neurologic disorder characterized by optic atrophy and peripheral sensorimotor neuropathy manifesting as axonal Charcot-Marie-Tooth disease. Charcot-Marie-Tooth disease is a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. It is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies and primary peripheral axonal neuropathies. Peripheral axonal neuropathies are characterized by signs of axonal regeneration in the absence of obvious myelin alterations, and normal or slightly reduced nerve conduction velocities. The disease is caused by variants affecting the gene represented in this entry.
609260 OMIMCharcot-Marie-Tooth disease 2A2A (CMT2A2A)An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. The disease is caused by variants affecting the gene represented in this entry.